secwatch.observer — SEC 8-K summary
======================================

Issuer:     Electromedical Technologies, Inc (EMED)
CIK:        0001715819
Form:       8-K
Filed at:   2022-09-23T23:59:59+00:00
Accession:  0001104659-22-102659
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.02, 5.01, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

CEO receives super-voting preferred shares, now controls 75.48% of voting power
-------------------------------------------------------------------------------

- Issued 500,000 Series A Preferred shares to CEO Matthew Wolfson as retention consideration; each share carries 100 votes.
- Wolfson now holds 1M Series A Preferred and 15.4M common shares, representing 75.48% of total voting power.
- Board increased authorized shares to 999M common, 1M Series A Preferred, and 1 Series B Preferred, approved by written consent.
- Wolfson committed to remain as PEO and PFO while employment agreement amendments are finalized.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1715819/000110465922102659/0001104659-22-102659-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1715819/000110465922102659/tm2226564d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-102659

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer